Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-01

FDA Approved: TINDAMAX — Supplemental Application (Mission Pharmacal Company)

View source ↗

Summary

The FDA approved a supplemental application for TINDAMAX (tinidazole) from Mission Pharmacal Company, resulting in an updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TINDAMAX (Tinidazole)

Snippet

SUPPL AP for TINDAMAX (TINIDAZOLE)